FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to pharmaceutical composition for intranasal administration contains zolmitriptan that is agonist of 5-HT1-receptor and pharmaceutically acceptable carrier. The composition has pH value less 6.0. The composition can be used for treatment of migraine and related disorders. The composition shows the improved stability in storage and provides effective relief for patients suffering with migraine.
EFFECT: improved and valuable medicinal properties of composition.
11 cl, 1 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING TRIPTANE COMPOUNDS | 2010 |
|
RU2710372C2 |
| COMPOSITIONS CONTAINING TRIPTANE COMPOUNDS | 2019 |
|
RU2762725C2 |
| PHARMACEUTICAL COMPOSITION | 2017 |
|
RU2767436C2 |
| USE OF CHOLINE SALT OF SUCCINIC ACID IN MANUFACTURE OF MEDICINAL AGENT FOR TREATMENT OF MIGRAINE | 2024 |
|
RU2837691C1 |
| PHARMACEUTICAL COMPOSITION COMPRISING 5HT1-RECEPTOR AGONIST | 2002 |
|
RU2285526C2 |
| SUBLINGUAL SPRAY COMPOSITION CONTAINING DIHYDROARTEMISININ | 2010 |
|
RU2501550C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING OR RELIEVING MOVEMENT DISORDERS AND ITS APPLICATION | 2011 |
|
RU2611376C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2604690C2 |
| COMPOSITIONS FOR DRUG INTRODUCTION | 2009 |
|
RU2554814C2 |
| TREATMENT OF GASTROPARESIS ASSOCIATED SYMPTOMS FOR WOMEN | 2012 |
|
RU2616520C2 |
